HYPD · Hyperion Defi, Inc.
Market Cap
$44.44M
Shares
15.54M
Volume · Oct 20
246.93K
Avg daily vol (3M)
458.8K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.86
Open$2.89
Day$2.84–2.99
52W close$2.34–8.35
Avg vol 30d500K
Short int1.1M · 7.3% float · 1.9d
Short vol86%
Last earningsNov 12, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 13
Up next
Next earnings call
Nov 12, 2026
Scheduled
· in 3 wks
filed Aug 13, 2026
call held Aug 12, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$1.40M
Trailing 12 months
Net income (TTM)
$6.65M
Trailing 12 months
Revenue growth YoY
+1,318.8%
Year over year
Operating margin
-5,743.5%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+384.3%
Year over year · more shares
Price change (1Y)
-60.7%
Trailing year
Short interest
7.3%
Latest settlement · 1.9 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Very Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.4 · elevated
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
Golden cross
Price vs 200-day avg
−15%
below
Price vs 50-day avg
−16%
below
RSI (14)
35
neutral
MACD trend
Negative
52-week position
9%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−26%
trailing
6-month return
−33%
trailing
YTD return
−20%
this year
Relative strength
−41%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Golden cross
50d $3 › 200d $3 — 50d above 200d
Institutional flow
Accumulating
1 of 33 funds reported for Sep 30 · net +11.3K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
7.28% of float · ▼ -8.9% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
33 holders — near 1-yr high, broad support
Squeeze score
49
elevated · 0–100
Fundamentals
Revenue growth
+1319%
Y/Y
Gross margin
63%
expanding
EPS growth
+84%
Y/Y
Free cash flow
$-14.9M
Quant / Vol
risk profile
Volatility
109%
annualized · 1-yr
Max drawdown
−72%
past year
ATR
9.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Aug 12, 2026
Adjusted gross profit
· 2026
Non-GAAP
$5M – $7M
Prior guidance
period ended
· from the 8-K filed Nov 13, 2025
Adjusted Revenues
· Q4'25
$475,000 – $515,000
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
Golden cross
Bullish
Price vs 200-day avg
−15%
Bearish
Price vs 50-day avg
−16%
Bearish
RSI (14)
35
Neutral
MACD trend
Negative
Bearish
52-week position
9%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 4 of 6
Trend (MA cross)
Golden cross
50d $3 › 200d $3 — 50d above 200d
Institutional flow
Accumulating
1 of 33 funds reported for Sep 30 · net +11.3K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
7.28% of float · ▼ -8.9% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
33 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $2
Now $3 · 9%
Range high $8
vs 200-day avg -15%
vs 50-day avg -16%
50-day above 200-day golden cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Cash, cash equivalents, and stablecoins | $14.5M | as of September 30, 2026 | — |
| Gross HYPE tokens | 1.85M | as of September 30, 2026 | — |
| Outstanding HYPD common shares | 15,442,482 | as of September 30, 2026 | — |
| % Earned in Cash non-GAAP | 50% | Q2'26 | — |
| Adjusted EBITDA non-GAAP | $53,652,846 | Q2 2026 | — |
| Adjusted Gross Profit non-GAAP | $1,150,035 | Q2'26 | — |
| Adjusted Net Investing Cash Flow non-GAAP | -$6,165,672 | Q2 2026 | — |
| Adjusted Net Operating Cash Flow non-GAAP | -$2,124,382 | Q2 2026 | — |
| Adjusted Other Income (Expense) non-GAAP | $31,919 | Q2 2026 | — |
| Effective Average HYPE Price In-Period non-GAAP | $51.23 | Q2'26 | — |
| Ending Cash, Cash Equivalents, and Stablecoins non-GAAP | $11,758,699 | Q2 2026 | — |
| Gross HYPE Holdings non-GAAP | $132,635,212 | As of June 30, 2026 | — |
| HYPE Earned in Staking & Validating non-GAAP | 11,115 | Q2'26 | — |
| HYPE held in treasury | 2.04M | July 31, 2026 | — |
| HYPE tokens delegated to our Validator non-GAAP | 7M | July 31, 2026 | — |
| HYPE tokens delegated to Validator | 7M | as of July 31, 2026 | — |
| HYPE tokens earned from staking and validating | 11.1K | Q2’26 | — |
| Net Asset Value non-GAAP | $134,226,478 | As of June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP HYPE digital assets, as adjusted to Gross HYPE Holdings $71,037,344
+$193,780 Add: KNTQ & sKNTQ at Carrying Value
+$149,820 Add: HPL & sHPL at Carrying Value
+$1,615,075 Add: Hyperion Rysk Vault Shares at Cost Basis
+$8,803,947 Add: Current Assets
-$4,509,992 Subtract: Current Liabilities
-$7,416,353 Subtract: Notes Payable
= Net Asset Value $69,873,504
|
|||
| Operating Expenses Excluding Stock-Based Compensation non-GAAP | $2,344,734 | Q2 2026 | — |
| Outstanding shares of HYPD common stock | 15,539,434 | as of August 10, 2026 | — |
| Treasury Gains (Losses) non-GAAP | $54,815,626 | Q2 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net Operating Income (Expenses) $30,650,049
+$58,492 Research and development expense
+$3,918,573 Selling, general and administrative expense
+$57,773 Impairment of right of use assets
-$909,842 Provision for credit losses
+$21,819,604 In-Period Change in unrealized accretion (dilution) expected upon LST to HYPE reconversion
-$255,275 Accumulated but unrealized staking yield on LSTs
-$18,699 Income from airdrops
-$42,035 Realized gains / losses from Rysk Vault shares redemption
-$112,032 Net gains on derivative instruments
-$351,000 Treasury losses (gains) attributable to derivative activity
= Treasury Gains (Losses) $54,815,626
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HYPD
this stock
Hyperion Defi, Inc.
|
$44.44M | -19.7% | +1318.8% | — | 7.3% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$130.07B | +10.7% | +46.2% | 29.9 | 1.8% |
|
MRNA
Moderna, Inc.
|
$90.58B | +669.4% | +4.3% | — | 7.7% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$80.51B | +1.3% | +20.8% | 19.4 | 2.1% |
|
CSLLY
Csl Ltd
|
$64.50B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HYPD | -17.6% | -25.7% | -32.9% | -23.6% | -19.7% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | -16.1% | -24.8% | -40.6% | -24.1% | -32.1% |